BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35861683)

  • 1. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
    Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
    Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 3. Remodeling the Tumor Microenvironment with Core-Shell Nanosensitizer Featuring Dual-Modal Imaging and Multimodal Therapy for Breast Cancer.
    Hou YK; Zhang ZJ; Li RT; Peng J; Chen SY; Yue YR; Zhang WH; Sun B; Chen JX; Zhou Q
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2602-2616. PubMed ID: 36622638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous NiB@IrO
    Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
    Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
    Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
    J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
    Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
    Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOF-based nanozyme grafted with cooperative Pt(IV) prodrug for synergistic anticancer therapy.
    Wu PH; Cheng PF; Kaveevivitchai W; Chen TH
    Colloids Surf B Biointerfaces; 2023 May; 225():113264. PubMed ID: 36921426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
    Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
    Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
    Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
    ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
    Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
    J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective NIR laser/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies.
    Cheng H; Wang X; Liu X; Wang X; Wen H; Cheng Y; Xie A; Shen Y; Tang R; Zhu M
    Nanoscale; 2021 Jun; 13(24):10816-10828. PubMed ID: 34113940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy.
    Zhang Z; Wang L; Guo Z; Sun Y; Yan J
    Colloids Surf B Biointerfaces; 2024 May; 237():113871. PubMed ID: 38547796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin Protein Corona-Modified CuGd Core-Shell Nanoplatform for Tumor-Targeting Photothermal and Chemodynamic Synergistic Therapies.
    Qi X; Wang G; Wang P; Pei Y; Zhang C; Yan M; Wei P; Tian G; Zhang G
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7659-7670. PubMed ID: 35119836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Stimuli-Responsive Nanoplatform Loaded Pt
    Fang K; Sun Y; Yang J; Hu X; Chen M; Li R; Yang X; Fan T; Wu J; Tong X; Dong C; Shi S
    Adv Healthc Mater; 2023 Nov; 12(28):e2301328. PubMed ID: 37392128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fe
    Chen T; Chu Q; Li M; Han G; Li X
    J Nanobiotechnology; 2021 Jul; 19(1):206. PubMed ID: 34246260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimetallic PtPd Atomic Clusters as Apoptosis/Ferroptosis Inducers for Antineoplastic Therapy through Heterogeneous Catalytic Processes.
    Wang X; He M; Zhao Y; He J; Huang J; Zhang L; Xu Z; Kang Y; Xue P
    ACS Nano; 2024 Mar; 18(11):8083-8098. PubMed ID: 38456744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Enzyme Cascade-Triggered Nitric Oxide Release Nanoplatform Combined with Chemo Starvation-like Therapy for Multidrug-Resistant Cancers.
    Li G; Lu X; Zhang S; Zhang J; Fu X; Zhang M; Teng L; Sun F
    ACS Appl Mater Interfaces; 2023 Jul; 15(26):31285-31299. PubMed ID: 37344958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.